Hycroft Mining (HYMC) had the best month in 2022 by a mid-cap US stock or mid-cap US stock in March 2022, returning 641.9%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Hycroft Mining (HYMC) | March 2022 | 641.94% |
Pharvaris (PHVS) | December 2022 | 425.7% |
Rhythm Pharmaceuticals (RYTM) | July 2022 | 208.82% |
Eos Energy Enterprises (EOSE) | July 2022 | 159.84% |
Viking Therapeutics (VKTX) | December 2022 | 131.53% |
F&G Annuities & Life (FG) | November 2022 | 129.9% |
Tango Therapeutics (TNGX) | October 2022 | 117.3% |
Miniso Group Holding (MNSO) | November 2022 | 117.1% |
Belite Bio Inc ADR (BLTE) | June 2022 | 105.54% |
Immunovant (IMVT) | October 2022 | 97.53% |
Enliven Therapeutics (ELVN) | September 2022 | 96.55% |
Cogent Biosciences (COGT) | June 2022 | 95.66% |
Spyre Therapeutics (SYRE) | October 2022 | 94.34% |
VEON (VEON) | November 2022 | 93.55% |
Enliven Therapeutics (ELVN) | October 2022 | 92.21% |
Bandwidth (BAND) | November 2022 | 91.62% |
Lantheus (LNTH) | February 2022 | 87.46% |
Nextdecade (NEXT) | March 2022 | 84.92% |
Nuvalent (NUVL) | October 2022 | 82.57% |
Rhythm Pharmaceuticals (RYTM) | August 2022 | 81.53% |
Vaxcyte (PCVX) | October 2022 | 78% |
Bilibili (BILI) | November 2022 | 77.51% |
Riot Platforms (RIOT) | July 2022 | 72.64% |
Calix (CALX) | July 2022 | 68.81% |
ADEIA (ADEA) | October 2022 | 68.12% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.